Thesite is secure.
The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The clinical and societal measurement of human sleep has increased exponentially in recent years. However, unlike other fields of medical analysis that have become highly automated, basic and clinical sleep research still relies on human visual scoring. Such human-based evaluations are time-consuming, tedious, and can be prone to subjective bias. Here, we describe a novel algorithm trained and validated on +30,000 hr of polysomnographic sleep recordings across heterogeneous populations around the world. This tool offers high sleep-staging accuracy that matches human scoring accuracy and interscorer agreement no matter the population kind. The software is designed to be especially easy to use, computationally low-demanding, open source, and free. Our hope is that this software facilitates the broad adoption of an industry-standard automated sleep staging software package.
These findings indicate that NREM SWA is a novel cognitive reserve factor providing resilience against the memory impairment otherwise caused by high AD pathology burden. Furthermore, this cognitive reserve function of NREM SWA remained significant when accounting both for covariates, and factors previously linked to resilience, suggesting that sleep might be an independent cognitive reserve resource. Beyond such mechanistic insights are potential therapeutic implications. Unlike many other cognitive reserve factors (e.g., years of education, prior job complexity), sleep is a modifiable factor. As such, it represents an intervention possibility that may aid the preservation of cognitive function in the face of AD pathology, both present moment and longitudinally.
However, a paradox has become increasingly clear: some individuals with high amounts of Aβ pathology suffer marked memory impairment, while others with the same degree of pathology burden show little impairment [11]. Why is this? One proposed explanation is cognitive reserve [12, 13], i.e., factors that offer compensation against the effects of substantive AD pathology.
Cognitive reserve factors identified to date include a greater number of years of education [14,15,16], higher occupational complexity [17, 18], and higher levels of physical activity [19, 20]. Nevertheless, even when combining all reserve factors identified to date, they explain only a modest degree of the full magnitude of cognitive reserve expressed across individuals [21]. This indicates that other such factors must exist that have yet to be identified.
Here, we propose that one novel and currently unexplored factor supporting cognitive reserve in the face of Aβ pathology burden is sleep, and specifically the quality of non-rapid eye movement slow wave sleep (NREM SWS). Five lines of evidence support this hypothesis.
First, a robust literature has demonstrated the beneficial effect of sleep on cognitive performance, particularly for hippocampal-dependent learning and memory [22, 23]. Second, manipulations of NREM SWS and the electroencephalographic (EEG) quality of NREM SWS (indexed in slow wave activity, SWA) causally enhance cognitive function in older adults, and in those with mild cognitive impairment [24, 25]. Third, selective deprivation of NREM SWA in older adults causally impairs hippocampal activity and associated learning, especially for item-based memory [26]. Fourth, Aβ burden is associated with impairments in NREM SWA, which in turn, predicts worse memory performance [27]. Fifth, degraded memory performance is associated with worse sleep efficiency, most prominently in individuals with high Aβ burden [28].
Despite such converging evidence, the possibility that NREM SWA represents a neurophysiological cognitive reserve factor that supports superior memory function under conditions of high Aβ burden remains untested. Of note, the proposal of NREM SWA as a cognitive reserve factor is dissociable from existing findings that show that impaired sleep is associated with worse and declining memory in older adults, and in those with AD pathology. Instead, the current hypothesis describes the opposite scenario: when facing severe AD pathology burden, NREM SWA beneficially mitigates against that high AD pathological state and supports superior cognitive function as a result. That is, we propose a new pathway through which sleep and cognitive function are connected in AD, namely a cognitive reserve pathway wherein NREM SWA confers protective compensation against existing AD pathology burden.
We tested this overarching hypothesis by combining 11C-PiB (Pittsburgh compound B) positron emission tomography (PET) scanning, which offers in vivo estimates of Aβ burden, with sleep EEG recordings quantifying NREM SWA, and a behavioral test of sleep-dependent hippocampal-related learning, focusing on item-based memory [26]. This design offered a test of the prediction that NREM SWA moderates the effect of Aβ pathology burden on memory function, such that NREM SWA supports superior cognitive performance under circumstances of high need for cognitive reserve, i.e., high Aβ burden. Thus, the study addressed the three formal components that have been described in the characterization of cognitive reserve [12, 13]: 1) a feature or disease measurement known to impact cognition (here, Aβ), 2) a measure of cognition (here, memory function), and 3) a variable that influences the relationship between Aβ and memory (here, NREM SWA).
All participants completed three sessions. In one session, participants underwent PET scanning following 11C-PiB injection to measure Aβ burden. Within 2 years of 11C-PiB PET scanning (median: 0.52 years, and see Table 1), participants completed the sleep study session. Participants spent two nights in the laboratory, where they were given 8-hour sleep opportunities monitored with polysomnography (PSG). This 8-hour interval was in accordance with age-appropriate averages [36], and the total sleep time of the participants was in the normative range [37] (Table 1). The first night served as an adaptation night to prevent first-night effects [38, 39], whereas the second served as the experimental night. Following the experimental night, structural MRI scans were obtained from all participants in the morning to measure gray matter atrophy. Subsequently, participants completed a hippocampal-dependent face-name memory task [40]. Four participants had missing data in the memory task due to not completing the task (N = 2) and insufficient number of certain response types (N = 2) resulting in an inability to compute memory measures (N = 1 missing measure for item and N = 1 missing measure for associative memory). Furthermore, BMI was not assessed for one participant and structural MRI was missing for one participant. All participants abstained from caffeine, alcohol, and daytime naps for 48 hours before and during the sleep study session. Participants kept habitual sleep-wake rhythms for at least 1 week preceding the in-laboratory sleep session and completed the in-laboratory sleep study in accordance with their individual rhythms. In a separate session (on average within a half year from the experimental sleep session, median: 0.44 years), participants also completed multiple questionnaires and cognitive tasks, including the assessment of physical activity in the last year [41] and a composite memory measure [42].
Data were scored using a validated automated sleep scoring software [46] and further assured with visual inspection by two trained sleep-scoring professionals (Z.Z. and O.M.) in accordance with standardized criteria [47]. In parallel to sleep scoring, 30-second epochs with major body movements were rejected based on visual inspection. Channels with marked artifact noise were also identified during visual inspection and omitted from subsequent analyses. To reduce artifacts, EEG data were re-referenced from the contralateral mastoids as needed to the average of the mastoids (N = 24) or a unilateral mastoid (N = 5). Furthermore, for any participant with slow drift artifacts due to sweating (N = 27), a semi-automatic, amplitude-based rejection was applied to their EEG data. For each affected participant, a sweat artifact-free, 30-second long epoch from deep sleep (NREM3 stage) was selected based on visual inspection. For each participant and for each EEG channel, the average bandpower between 0.2 and 0.8 Hz in this sweat artifact-free epoch was computed. Further EEG data was rejected on a 5-second basis whenever the bandpower between 0.2 and 0.8 Hz exceeded 1.5 times the individual amplitude of the clean epoch in any of 3 frontal channels (F3, F4, Fz). Frontal channels were specifically selected as the sweat artifact was expressed the strongest in those channels.
Next-day memory was assessed using a validated, face-name hippocampal-dependent task sensitive to age and sleep effects [40, 49, 50]. This task has been proven to have good reliability in older adults [51,52,53]. The task consisted of an encoding phase where 120 face-name pairs were introduced and a recognition test that followed the end of the encoding phase after a 30-minute delay [40].
Two distinct d-prime sensitivity memory measures were computed based on the recognition test. Item memory performance was quantified by subtracting the standardized false alarm rate for the faces (the proportion of faces falsely declared to be previously seen out of all the foil trials) from the standardized hit rate for previously encoded faces (the proportion of faces correctly recognized as previously seen out of all the encoded face trials). Associative memory was quantified by subtracting the standardized lure (miss) rate (the proportion of misses, where participants chose the lure names instead of the correct answer out of all previously encoded trials where the participant correctly identified the face as being previously studied) from the standardized hit rate of the face-name pairs (the proportion of faces and names correctly paired out of all previously encoded trials where the participant correctly identified the face as being previously studied).
3a8082e126